Dr Shafinaz Karim & Dr Susan Benson 29 June 2015
Clinical Care Standards Appropriateness of clinical care is a major focus in improving
the quality of health care provision
Antimicrobial Stewardship - collective set of strategies
Aims to ensure that a patient with a bacterial infection receives optimal treatment with antibiotics
To minimize the adverse effects of antibiotic use including resistance, toxicity and costs
WAIDPG Guidelines
Adherence to best practice management for blood stream infections (bacteraemia) – Staphyloccocus aureus bacteraemia
Staphylococcus aureus
Skin and soft tissue infection
Systemic infection
Staphylococcus aureus is a serious blood stream infection 3 ,4
Mortality - high as 40%
Recognised complications – endocarditis, bone and joint infections
Early optimal therapy to improve outcomes led to
development of guidelines for management of SAB
(WAIDPG, Infections and Immunology Health Network, WA Health, 2012)5
Aim
To measure adherence to best practice guidelines for management of SAB
in adult patients and identify target areas for improvement.
Objectives
In adult patients with positive blood cultures of Staphylococcus aureus at
Armadale Hospital, what proportion receives best practice SAB
management outlined by WAIDPG, Department of Health WA.
Retrospective audit 31 Jan 2013 – 31 May 2014 (17 months)
Pathwest lab database- All + ve Blood cultures at AHS (Filter “S. aureus”)
Exclusion criteria: Under 18 years old Positive blood cultures after
patient transferred Files not available
Identified standards: Empiric anti-Staphyloccocal antibiotics selection and dose Proportion of S.aureus cultures that are methicillin resistant Echocardiography organized before discharge Blood culture repeated >72 hours Infectious disease physician bedside consult
Demographics: Age Gender Date of admission Health care-associated
infection (+ve b/c greater than 48hrs or
SAB at Armadale = 1-2 episodes per month
M = 15 (60%) / F = 10 (40%) Mean Age= 62 years (20-98)
HAIs = 4/25 (14%) Non-HAIs = 20/25 (80%)
MRSA = 6/25 (24%) MSSA = 19/25 (76%)
Crude mortality:
1/25 (4%)
(AIHW, 2013) A case of SAB is considered to be healthcare-associated if the first positive blood test is more than 48 hours after hospital admission HAIs more than 48 hours after hospital admission or if the first positive blood test is 48 hours or less after admission and one of the following criteria was met: 1. SAB is a complication of the presence of an indwelling medical device (for example, intravascular line, haemodialysis vascular access, cerebrospinal fluid shunt, urinary catheter). 2. SAB occurs within 30 days of a surgical procedure where the SAB is related to the surgical site. 3. An invasive instrumentation or incision related to the SAB was performed within 48 hours. 4. SAB is associated with neutropenia (
0
5
10
15
20
25
30
Concordant with guidelines Not concordant with guidelines
Nu
mb
er
of
pa
tie
nts
Antibiotic choice as per guidelines recommendations (microbiology advice)
4%
96%
0
1
2
3
4
5
6
7
8
9
10
Concordant withguidelines
Not concordant withguidelines
Nu
mb
er
of
pa
tie
nts
Given loading dose of Vancomycin
3
7
5
6
0
2
4
6
8
10
12
14
Cephazolin Flucloxacillin
Nu
mb
er
of
pa
tie
nts
B-lactams dose and dose interval
Not concordant with guidelines Concordant with guidelines
38%
46%
54%
Loading dose Vancomycin (25mg/kg)
40%
60%
62%
Cephazolin 2G TDS or Flucloxacillin 2G 6hrly (norm renal fn)
15 18
23
10 4
2
0
5
10
15
20
25
30
B/C repeated >72hours Echo performed ID Consult
Nu
mb
er
of
pa
tie
nts
Best Practice Management of SAB
Achieved standard Did not achieve standard
72%
16%
92%
8%
60%
40%
Antibiotic prescribing
96% concordance with antibiotic choice as per micro advice
40% concordance with vancomycin loading dose
54% concordance with flucloxacillin dose and dose interval
Investigations
60% achieved standard for b/c >72h
72% achieved standard for echo before d/c Bedside ID review
92% achieved standard
16% HAIs of these 75% are secondary to IV line related infection
Staphylococcal sepsis not suspected on admission, 32%
misdiagnosed as pneumonia
D/C Summaries: Diagnosis of SAB?
65% mentioned SAB
Poor documentation of antibiotic prescribing in medication chart
Critical results documentation
“Hey interns! Do you document in the progress notes when you have been called
by Micro regarding a positive blood culture?”
22 19
0
5
10
15
20
25
YES NO
Microcall documentation in MR55
Survey - 24th June 2015
“Just look on the system”
“Should we?”
“I didn’t know we had to?!”
“Next day, on ward rounds”
1. Vancomycin loading dose 2. B-lactams higher dosing 3. Critical results documentation 4. Documentation in medical notes 5. Documentation in medication chart
New vancomycin dosing flow sheet Good documentation and SAB guidelines - included in
RMO orientation and teaching NAPS audit (June 2015) and survey items were extended
to measure antibiotic documentation UNDF student audit - specifically addresses the
documentation of critical results RMO bulletin - included the need for documentation of
critical results Ongoing lobbying: SAB guideline name changed so that
it can be easier found on the local intranet
Need for safer systems, organizations & processes of care
Using opinion leaders and clinical ‘champions’
Endorsement by key clinical and administrative groups
Reminder systems incorporated in clinician’s daily work
Local involvement in evaluation
Continuing quality assurance and data feedback
Routine in Clinical Practice
Dr Susan Benson Mr Graham Francis (Microbiology Fremantle PathWest) Dr Tristan Gibbs (Microbiology RPH PathWest) Clinical quality and safety committee,
Armadale Hospital
Questions?
1. Australian Commission on Safety and Quality in Health Care (ACSQHC) (September 2011),
National Safety and Quality Health Service Standards, ACSQHC, Sydney.
2. Australian Commission on Safety and Quality in Health Care. Antimicrobial Stewardship
Clinical Care Standard. Sydney: ACSQHC, 2014.
3. Australian Institute of Health and Welfare. (2013). Staphylococcus bacteraemia in Australian
public hospitals. Retrieved from
http://www.aihw.gov.au/WorkArea/DownloadAsset.aspx?id=60129542613
4. Kern, W.V. (2010). Management of Staphylococcus Aureus bacteraemia and endocarditis:
progresses and challenges. Current Opinion in Infectious Diseases, 23, 346–358
5. Management of Staphylococcus aureus bacteraemia, WAIDPG, Infections and Immunology
Health Network, WA Health, 2012